Trans Pacific Partnership / Clinton Foundation Partnership / WHO Consultative Expert Working Group / Inside US Trade / The Australian Fair Trade / /
Country
Guatemala / New Zealand / Chile / Brunei / Peru / Thailand / Colombia / Malaysia / Jordan / United States / Brazil / Vietnam / Australia / India / /
Currency
USD / /
IndustryTerm
pharmaceuticals and medical devices / pharmaceutical product / pharmaceutical industry / supply chain management / prevention products / HIV prevention / human rights law / pharmaceutical intellectual property / pharmaceutical / pharmaceutical coverage programs / direct-to-consumer advertising / HIV treatment / pharmaceuticals / extreme pharmaceutical intellectual property / chemical entities / treatment for HIV / patent law / pharmaceutical industry influence / pharmaceutical products / pharmaceutical pricing / /
MedicalCondition
TB / HIV / non-communicable diseases / HIV infections / opportunistic infections / Malaria / AIDS / HIV/AIDS / infectious disease / tuberculosis / /
Organization
Global Commission on HIV / Foundation for AIDS Research / World Health Organization / Public Health Association of Australia / Oxfam / Department of Foreign Affairs and Trade / Therapeutic Goods Administration / Australian Government / World Trade Organization / PEPFAR / Medecins Sans Frontieres / Labor Government / WHO Regional Office for South-East Asia / Productivity Commission / Global Fund for AIDS / Global Fund / civil society / United Nations / Australian Federation of AIDS Organisations / Global Fund for AIDS / TB and Malaria / AusAID / Clinton Foundation / United States Trade Representative / Public Citizen / European Union / Australia Australian Medical Students’ Association / unaids / /
Submission to the Department of Foreign Affairs and Trade: The Trans Pacific Partnership Agreement, Intellectual Property and Medicines 1 October, 2013